Clinical trial · Interventional
A Stress Management and Resiliency Program for Adolescent and Young Adult Survivors
A Stress Management and Resiliency Program for Adolescent and Young Adult Cancer Survivors
NCT03768336CI-TRIAL-00108176active not recruitingN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This research study aims to explore the feasibility and acceptability of an adapted resiliency group program, called the Relaxation Response Resiliency Program (3RP-AYA), to reduce stress and promote stress-management among adolescents and young adults who have completed treatment for cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| 3RP-AYA | Other | — | UNRESOLVED |
| Waitlist control | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Waitlist Control
- description
- * The 3RP-AYA will be delivered in weekly sessions over the course of approximately 8 weeks, for a total of 8 sessions * Mini relaxation practice * Weekly goal check-ins * RR-practice
- interventionNames
- Other: Waitlist control
- type
- EXPERIMENTAL
- label
- 3RP Group Sessions
- description
- * The 3RP-AYA will be delivered in weekly sessions over the course of approximately 8 weeks, for a total of 8 sessions * Mini relaxation practice * Weekly goal check-ins * RR-practice
- interventionNames
- Other: 3RP-AYA
Primary outcomes (3)
- measure
- 3RP-AYA Feasibility: Percent of Identified Eligibles Who Enroll
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 16 Years
- Maximum age
- 29 Years
Show eligibility criteria text
Inclusion Criteria: * Diagnosed with any cancer between ages 14 and 29 * Completed cancer treatment within the past 5 years * At least 16 years of age at time of enrollment Exclusion Criteria: * Unwilling or unable to participate in the study * Unable to speak or read English * Is medically or otherwise unable to participate (as determined by a physician or study PI) * Unwilling or unable to participate in study sessions delivered via the Partners Telehealth videoconferencing software * Participation in a focus group during Phase 1 (DF/HCC 17-315)
References
Publications (1)
- DERIVEDMizrach H, Goshe B, Park ER, Recklitis C, Greer JA, Chang Y, Frederick N, Abrams A, Tower MD, Walsh EA, Huang M, Kenney L, Homans A, Miller K, Denninger J, Usmani GN, Peppercorn J, Perez GK. Randomized Waitlist-Control Trial of a Web-Based Stress-Management and Resiliency Program for Adolescent and Young Adult Cancer Survivors: Protocol for the Bounce Back Study. JMIR Res Protoc. 2022 Jan 26;11(1):e34033. doi: 10.2196/34033. PMID 35080500